Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine Versus Nimenrix in Healthy Adolescents: A Randomized Phase IIIb Multicenter Study.
Javier Díez-DomingoRóbert SimkóGiancarlo IcardiChan Poh ChongCéline ZocchettiOlga SyrkinaSiham BchirIsabelle Bertrand-GerentesPublished in: Infectious diseases and therapy (2024)
Clinicaltrials.gov, NCT04490018; EudraCT: 2020-001665-37; WHO: U1111-1249-2973.